Related Experiment Video
Updated: Jan 14, 2026
Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
The CT-based attenuation index of peri-bowel adipose tissue can predict disease progression in inflammatory bowel
Jun Lu1, Hui Xu1, Jingxuan Zhang1
1Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Objectives:
Peri-bowel fat inflammation is a prominent feature of inflammatory bowel disease (IBD). The peri-bowel fat attenuation index (FAI) can capture fat inflammation on abdominal CT. This study aimed to investigate the prognostic value of the peri-bowel FAI in IBD patients.
Materials And Methods:
Totally, 207 IBD patients were retrospectively collected. Regions of interest were placed at 5 different locations, namely, mesenteric side (MS) and opposite side of MS (OMS) around the most severe bowel lesion, spaces around the normal bowel wall (Nor), retroperitoneal space (RS), and subcutaneous area. The Kaplan-Meier curves were plotted. The prognostic value of the peri-bowel FAI was evaluated by multivariable Cox regression models.
Results:
High peri-bowel FAI values of MS and OMS were predictors of disease progression and correlated strongly with each other (r = 0.840, p < 0.001), while the FAI of Nor and RS were not. Therefore, peri-bowel FAI of MS was used as a representative biomarker for the prediction of IBD disease progression (HR = 1.161 [1.110-1.215], p < 0.001) with an optimum cutoff of 25.1 HU, which was confirmed in the subgroup analysis with different disease subtypes. With the addition of the peri-bowel FAI to the current noninvasive risk prediction model, the AUC increased from 0.706 (0.638-0.767) to 0.864 (0.810-0.90) with integrated discrimination improvement (IDI = 0.293 [0.229-0.356], p < 0.001) and net reclassification improvement (NRI = 1.053 [0.821-1.284], p < 0.001).
Conclusion:
The peri-bowel FAI is promising for IBD disease progression prediction and risk stratification by quantifying peri-bowel fat inflammation. High peri-bowel FAI values are an independent indicator of increased IBD disease progression and could guide early targeted prevention and intensive therapy.
Key Points:
Questions The peri-bowel fat attenuation index (FAI) helps detect peri-bowel fat inflammation noninvasively, but its importance for risk stratification and prediction of clinical outcomes remains unknown. Findings The peri-bowel FAI was an independent predictor of inflammatory bowel disease (IBD) disease progression with an optimum cutoff of 25.1 HU. Clinical relevance The peri-bowel FAI is a promising biomarker for contributing to the identification of so-called high-risk patients with uncontrolled inflammation, who might be candidates for more intensive treatment for addressing underlying inflammation at early stages and ultimately improve long-term prognosis.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...